Adamas Pharmaceuticals Inc
Adamas Pharmaceuticals Inc (ADMS) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 264 transactions totaling $45.3M, demonstrating a bearish sentiment with -$9.7M in net insider flow. The most recent transaction on Nov 24, 2021 involved a transaction of 202,000 shares valued at $0.
ADMS Insider Activity Summary
Who Is Buying ADMS Stock?
No significant insider buying has been recorded for ADMS in the recent period.
Who Is Selling ADMS Stock?
No significant insider selling has been recorded for ADMS in the recent period.
Is Adamas Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ADMS is bearish with an Insider Alignment Score of 39/100 and a net flow of -$9.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ADMS Frequently Asked Questions
Understanding ADMS Insider Activity
Insider trading at Adamas Pharmaceuticals Inc (ADMS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading ADMS stock, having executed 264 transactions in the past 90 days. The most active insider is William W. Ericson (Executive), who has made 33 transactions totaling $13.4M.
Related Tools
Track Adamas Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at ADMS file new Form 4 transactions